Highlights Early diagnosis of COVID-19 is of paramount importance to break the chain of transition and flatten the epidemic curve. Imaging techniques provide higher sensitivity, and they are more easily accessible, compared to the current gold standard. Capsule Networks can efficiently handle availability of limited datasets in case of COVID-19 pandemic. The proposed COVID-CAPS framework outperforms its CNN-based counterparts with far less number of trainable parameters. A new dataset is constructed from an external dataset of X-ray images for pre-training the proposed COVID-CAPS.
Brain tumor is considered as one of the deadliest and most common form of cancer both in children and in adults. Consequently, determining the correct type of brain tumor in early stages is of significant importance to devise a precise treatment plan and predict patient's response to the adopted treatment. In this regard, there has been a recent surge of interest in designing Convolutional Neural Networks (CNNs) for the problem of brain tumor type classification. However, CNNs typically require large amount of training data and can not properly handle input transformations. Capsule networks (referred to as CapsNets) are brand new machine learning architectures proposed very recently to overcome these shortcomings of CNNs, and posed to revolutionize deep learning solutions. Of particular interest to this work is that Capsule networks are robust to rotation and affine transformation, and require far less training data, which is the case for processing medical image datasets including brain Magnetic Resonance Imaging (MRI) images. In this paper, we focus to achieve the following four objectives: (i) Adopt and incorporate CapsNets for the problem of brain tumor classification to design an improved architecture which maximizes the accuracy of the classification problem at hand; (ii) Investigate the over-fitting problem of CapsNets based on a real set of MRI images; (iii) Explore whether or not CapsNets are capable of providing better fit for the whole brain images or just the segmented tumor, and; (iv) Develop a visualization paradigm for the output of the CapsNet to better explain the learned features. Our results show that the proposed approach can successfully overcome CNNs for the brain tumor classification problem.
Recent advancements in signal processing and machine learning coupled with developments of electronic medical record keeping in hospitals and the availability of extensive set of medical images through internal/external communication systems, have resulted in a recent surge of significant interest in "Radiomics". Radiomics is an emerging and relatively new research field, which refers to extracting semi-quantitative and/or quantitative features from medical images with the goal of developing predictive and/or prognostic models, and is expected to become a critical component for integration of image-derived information for personalized treatment in the near future. The conventional Radiomics workflow is typically based on extracting pre-designed features (also referred to as hand-crafted or engineered features) from a segmented region of interest. Nevertheless, recent advancements in deep learning have caused trends towards deep learning-based Radiomics (also referred to as discovery Radiomics). Considering the advantages of these two approaches, there are also hybrid solutions developed to exploit the potentials of multiple data sources. Considering the variety of approaches to Radiomics, further improvements require a comprehensive and integrated sketch, which is the goal of this article. This manuscript provides a unique interdisciplinary perspective on Radiomics by discussing state-of-the-art signal processing solutions in the context of Radiomics.
According to official statistics, cancer is considered as the second leading cause of human fatalities. Among different types of cancer, brain tumor is seen as one of the deadliest forms due to its aggressive nature, heterogeneous characteristics, and low relative survival rate. Determining the type of brain tumor has significant impact on the treatment choice and patient's survival. Human-centered diagnosis is typically error-prone and unreliable resulting in a recent surge of interest to automatize this process using convolutional neural networks (CNNs). CNNs, however, fail to fully utilize spatial relations, which is particularly harmful for tumor classification, as the relation between the tumor and its surrounding tissue is a critical indicator of the tumor's type. In our recent work, we have incorporated newly developed CapsNets to overcome this shortcoming. CapsNets are, however, highly sensitive to the miscellaneous image background. The paper addresses this gap. The main contribution is to equip CapsNet with access to the tumor surrounding tissues, without distracting it from the main target. A modified CapsNet architecture is, therefore, proposed for brain tumor classification, which takes the tumor coarse boundaries as extra inputs within its pipeline to increase the CapsNet's focus. The proposed approach noticeably outperforms its counterparts.
Novel Coronavirus (COVID-19) has drastically overwhelmed more than 200 countries affecting millions and claiming almost 2 million lives, since its emergence in late 2019. This highly contagious disease can easily spread, and if not controlled in a timely fashion, can rapidly incapacitate healthcare systems. The current standard diagnosis method, the Reverse Transcription Polymerase Chain Reaction (RT- PCR), is time consuming, and subject to low sensitivity. Chest Radiograph (CXR), the first imaging modality to be used, is readily available and gives immediate results. However, it has notoriously lower sensitivity than Computed Tomography (CT), which can be used efficiently to complement other diagnostic methods. This paper introduces a new COVID-19 CT scan dataset, referred to as COVID-CT-MD, consisting of not only COVID-19 cases, but also healthy and participants infected by Community Acquired Pneumonia (CAP). COVID-CT-MD dataset, which is accompanied with lobe-level, slice-level and patient-level labels, has the potential to facilitate the COVID-19 research, in particular COVID-CT-MD can assist in development of advanced Machine Learning (ML) and Deep Neural Network (DNN) based solutions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with đź’™ for researchers
Part of the Research Solutions Family.